-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Sign up for news updates
Lung Cancer Risk Reduction & Prevention
-
Tobacco Endgame: A Critical Frontier for Lung Cancer Prevention and Equity
Drs. Babalola Faseru and Carolyn Dresler outline strategies to shift the paradigm from tobacco control to tobacco elimination, including expanded cessation and early-detection infrastructure.
-
Rescission of EPA Finding Prompts Concern About Impacts on Cancer Care
Experts, including Dr. Joan H. Schiller, warn of devastating impacts to public health and the environment after the US government shuts down federal efforts to curb greenhouse gas emissions.
-
National Report Shows Rising Lung Cancer Survival Rates but Gaps in Early Detection
The ALA’s 2025 State of Lung Cancer report highlights survival gains while revealing persistent disparities in diagnosis, treatment, and access to biomarker testing.
-
Potential Improvement in Lung Cancer Deaths and Overall Mortality With Integration of Smoking Cessation and Lung Cancer Screening
By Lawson Eng, MD, FRCPC, and William K. Evans, MD, FRCPC Posted: August 21, 2020 IN REFERENCE TO: Cao P, Jeon J, Levy DT, et al. Potential impact of cessation interventions at the point of lung cancer screening on lung cancer and overall mortality in the United States. J Thorac Oncol. 2020. [Epub ahead of…
-
Smoking Cessation After Cancer Diagnosis: A Neglected Problem
By Jacek Jassem, MD, PhD, and Carolyn Dresler, MD, MPA Posted: August 21, 2020 The world is currently overwhelmed with cases of the novel virus COVID-19 and its devastating death toll. We acknowledge that finding a treatment, cure, and vaccine is currently our nations’ first responsibility. Amidst this, however, all of our underlying diseases continue…
-
Sustained Funding Vital for Smoking-Cessation Efforts
By Leah K. LawrencePosted: August 21, 2020 In July 2019, England’s government announced its goal to make the country “smoke free” by 2030.1 That may be easier said than done, however, according to a new joint report put out by Action on Smoking Health (ASH) and Cancer Research UK (CRUK).2 The annual report showed that…
-
Disparities in Meeting Eligibility Criteria for Lung Cancer Screening
By Kim L. Sandler, MD, Melinda C. Aldrich, MPH, PhD, and Jeffrey D. Blume, PhD Posted: April 16, 2020 IN REFERENCE TO: Aldrich MC, Mercaldo SF, Sandler KL, Blot WJ, Grogan EL, Blume JD. Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers. JAMA Oncol. 2019 Jun 27. [Epub ahead of print].…
-
A Cloud-Based Computerized System for the Korean Lung Cancer Screening Project
By Jin Mo Goo, MD, PhD, and Yeol Kim, MD, MPH, PhD Posted: April 16, 2020 Dr. Jin Mo Goo Dr. Yeol Kim In 2015, based on the evidence from the National Lung Screening Trial, the Korean multisociety collaborative committee developed and published a…
-
Improving Lung Nodule Evaluation Through Identification of Additional Features
By David Yankelevitz, MD Posted: August 14, 2019 IN REFERENCE TO: Peikert T, Rajagopalan S, Karwoski RA, et al. Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial. PLoS One. 2018;13(10). e0196910 The article “Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening…
-
The IASLC’s Spotlight on Screening
By James L. Mulshine, MD, and John K. Field, PhD, FRCPath Posted: March 1, 2019 The IASLC is supporting a new early thoracic CT image archive to encourage both quality measures and research for early lung cancer detection and management. This effort, the IASLC’s Early Lung Imaging Confederation (ELIC), is planned to have global reach…
View ILCN Archives
Provider Resources
Popular Articles